Harris R - Search Results

1

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.

Boumelha J, de Carné Trécesson S, Law EK, Romero-Clavijo P, Coelho MA, Ng KW, Mugarza E, Moore C, Rana S, Caswell DR, Murillo M, Hancock DC, Argyris PP, Brown WL, Durfee C, Larson LK, Vogel RI, Suárez-Bonnet A, Priestnall SL, East P, Ross SJ, Kassiotis G, Molina-Arcas M, Swanton C, Harris R, Downward J. Boumelha J, et al. Among authors: harris r. Cancer Res. 2022 Oct 4;82(19):3435-3448. doi: 10.1158/0008-5472.CAN-22-0325. Cancer Res. 2022. PMID: 35930804 Free PMC article.

2

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.

Liddament MT, Brown WL, Schumacher AJ, Harris RS. Liddament MT, et al. Curr Biol. 2004 Aug 10;14(15):1385-91. doi: 10.1016/j.cub.2004.06.050. Curr Biol. 2004. PMID: 15296757 Free article.

3

The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.

Schumacher AJ, Haché G, Macduff DA, Brown WL, Harris RS. Schumacher AJ, et al. J Virol. 2008 Mar;82(6):2652-60. doi: 10.1128/JVI.02391-07. Epub 2008 Jan 9. J Virol. 2008. PMID: 18184715 Free PMC article.

4

Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Refsland EW, et al. Nucleic Acids Res. 2010 Jul;38(13):4274-84. doi: 10.1093/nar/gkq174. Epub 2010 Mar 22. Nucleic Acids Res. 2010. PMID: 20308164 Free PMC article.

5

The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombination.

Demorest ZL, MacDuff DA, Brown WL, Morham SG, Parise LV, Harris RS. Demorest ZL, et al. PLoS One. 2010 Jul 20;5(7):e11660. doi: 10.1371/journal.pone.0011660. PLoS One. 2010. PMID: 20652029 Free PMC article.

6

Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.

Albin JS, Haché G, Hultquist JF, Brown WL, Harris RS. Albin JS, et al. J Virol. 2010 Oct;84(19):10209-19. doi: 10.1128/JVI.00632-10. Epub 2010 Aug 4. J Virol. 2010. PMID: 20686027 Free PMC article.

7

A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif.

Albin JS, LaRue RS, Weaver JA, Brown WL, Shindo K, Harjes E, Matsuo H, Harris RS. Albin JS, et al. J Biol Chem. 2010 Dec 24;285(52):40785-92. doi: 10.1074/jbc.M110.173161. Epub 2010 Oct 22. J Biol Chem. 2010. PMID: 20971849 Free PMC article.

8

Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1.

Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS. Hultquist JF, et al. J Virol. 2011 Nov;85(21):11220-34. doi: 10.1128/JVI.05238-11. Epub 2011 Aug 10. J Virol. 2011. PMID: 21835787 Free PMC article.

9

First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.

Li M, Shandilya SM, Carpenter MA, Rathore A, Brown WL, Perkins AL, Harki DA, Solberg J, Hook DJ, Pandey KK, Parniak MA, Johnson JR, Krogan NJ, Somasundaran M, Ali A, Schiffer CA, Harris RS. Li M, et al. Among authors: harris rs. ACS Chem Biol. 2012 Mar 16;7(3):506-17. doi: 10.1021/cb200440y. Epub 2012 Jan 17. ACS Chem Biol. 2012. PMID: 22181350 Free PMC article.

10

APOBEC3B and AID have similar nuclear import mechanisms.

Lackey L, Demorest ZL, Land AM, Hultquist JF, Brown WL, Harris RS. Lackey L, et al. J Mol Biol. 2012 Jun 22;419(5):301-14. doi: 10.1016/j.jmb.2012.03.011. Epub 2012 Mar 23. J Mol Biol. 2012. PMID: 22446380 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,808 results

Search Page